Builders FirstSource enters the final stretch before its July 30 earnings with options traders turning notably more defensive — a shift that stands out against an otherwise muted short-selling picture.
The clearest tension this week is in the options market. The put/call ratio has jumped to 0.53, more than 2.5 standard deviations above its 20-day average of 0.45 — the most elevated hedging posture the stock has seen in months, though still well below its 52-week peak of 1.13. That divergence matters: participants are buying more downside protection than usual, yet the ratio is nowhere near panic territory. The move arrived as the stock slipped 2.6% on the week to $76.73, extending a rough run that has left BLDR down roughly 18% year-to-date. Peers were broadly weaker too — TREX fell 2.2% and FBIN dropped 5.5% on the week — so some of the pressure is sector-wide, but BLDR's options skew is more pronounced than the move in price alone would suggest.
Short interest tells a less aggressive story than the options positioning implies. Bears hold about 7.6% of the free float short — a meaningful level, but one that has drifted lower over the past month, down roughly 3.6% from where it was 30 days ago. The week-on-week tick of +2.5% is a modest rebuild rather than a conviction surge. Crucially, the borrow market remains very loose: availability is running near 953%, meaning roughly nine shares are available to borrow for every one already lent out. That compares to a 52-week low availability of 363% — even at its tightest point this year, the lending pool was ample. Cost to borrow has crept up about 25% in the past month to 0.53%, but in absolute terms that is still an exceptionally cheap borrow. Shorts face no mechanical squeeze pressure from the lending side.
The Street's view is mixed, and the recent analyst history points to a pattern of broad target reductions rather than rating downgrades. Following the April 30 earnings print — which sent the stock down 9.2% in a single session — analysts from UBS, RBC, Barclays, Keybanc, and Benchmark all trimmed targets while holding positive ratings. The mean target now sits well above the current price, with UBS at $122 and Barclays at $93, but those numbers come from May 1 revisions and the stock has continued to drift lower since. The consensus has stalled at "hold" with ten analysts on the sidelines. Factor scores reflect the ambivalence: the short score ranks in only the 20th percentile, suggesting bears are not especially crowded relative to history, while EPS surprise ranks near the bottom of the universe at the 3rd percentile and the 90-day EPS momentum score sits at just 5 — signalling the earnings revision trend has been firmly negative. The 30-day EPS momentum score of 73 offers a sliver of encouragement, but it has not yet translated into analyst conviction. Valuation is undemanding: the PE has expanded modestly to about 16x over the past month, while EV/EBITDA has compressed to roughly 10.2x.
The earnings history reinforces why options traders are bracing. The last two quarterly prints each delivered a one-day drop of around 9% and a five-day loss of 4-6%. That is a consistent pattern of post-results selling, and with the next report due July 30 — just five weeks away — the pickup in put demand is structurally logical rather than purely speculative.
The key question heading into July 30 is whether the modest improvement in 30-day EPS momentum signals a genuine bottoming in the revision cycle, or whether housing-market softness and margin pressure produce a third consecutive heavy-selling reaction.
See the live data behind this article on ORTEX.
Open BLDR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
